KELLY LAWRENCE W & ASSOCIATES INC/CA - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 2 filers reported holding GW PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
KELLY LAWRENCE W & ASSOCIATES INC/CA ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$25,000
+127.3%
1150.0%0.01%
+100.0%
Q3 2020$11,000
-21.4%
1150.0%0.00%0.0%
Q2 2020$14,000
+40.0%
1150.0%0.00%
+50.0%
Q1 2020$10,000
-16.7%
1150.0%0.00%0.0%
Q4 2019$12,000
-7.7%
1150.0%0.00%0.0%
Q3 2019$13,000
-35.0%
1150.0%0.00%
-33.3%
Q2 2019$20,0001150.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2021
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders